JP2013528625A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013528625A5 JP2013528625A5 JP2013513408A JP2013513408A JP2013528625A5 JP 2013528625 A5 JP2013528625 A5 JP 2013528625A5 JP 2013513408 A JP2013513408 A JP 2013513408A JP 2013513408 A JP2013513408 A JP 2013513408A JP 2013528625 A5 JP2013528625 A5 JP 2013528625A5
- Authority
- JP
- Japan
- Prior art keywords
- angptl4
- polypeptide derivative
- angptl4 polypeptide
- seq
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35186610P | 2010-06-05 | 2010-06-05 | |
| US61/351,866 | 2010-06-05 | ||
| PCT/US2011/039255 WO2011153525A2 (en) | 2010-06-05 | 2011-06-06 | Methods for treatment of nephrotic syndrome and related conditions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013528625A JP2013528625A (ja) | 2013-07-11 |
| JP2013528625A5 true JP2013528625A5 (https=) | 2014-07-31 |
| JP5904560B2 JP5904560B2 (ja) | 2016-04-13 |
Family
ID=45067339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013513408A Active JP5904560B2 (ja) | 2010-06-05 | 2011-06-06 | ネフローゼ症候群および関連容態の治療のための方法 |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP3318269B1 (https=) |
| JP (1) | JP5904560B2 (https=) |
| KR (1) | KR20130132375A (https=) |
| CN (2) | CN103140234B (https=) |
| AU (1) | AU2011261196B2 (https=) |
| CA (1) | CA2801579C (https=) |
| DK (1) | DK2575858T3 (https=) |
| ES (1) | ES2663096T3 (https=) |
| NO (1) | NO2575858T3 (https=) |
| PL (1) | PL2575858T3 (https=) |
| PT (1) | PT2575858T (https=) |
| WO (1) | WO2011153525A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9139629B2 (en) | 2010-06-05 | 2015-09-22 | The Uab Research Foundation | Methods for treatment of nephrotic syndrome and related conditions |
| US20110301103A1 (en) | 2010-06-05 | 2011-12-08 | Chugh Sumant S | Methods of Treatment |
| WO2014145275A1 (en) | 2013-03-15 | 2014-09-18 | The Uab Research Foundation | Methods for treatment of nephrotic syndrome and related conditions |
| CN106170700A (zh) * | 2014-01-20 | 2016-11-30 | 玛丽亚·阿黛尔·西尔维亚·丹尼杰奥派德4有限公司 | 用于狼疮肾炎的治疗性随访中的预测、诊断和监测的体外方法 |
| EP4479079A4 (en) * | 2022-02-14 | 2026-02-18 | Sumant Singh Chugh | METHODS OF TREATMENT OF A CYTOKINE STAMP DISEASE WITH A RECOMBINANT TYPE 4 MUTANT HUMAN ANGIOPOIETIN |
| CN114934021B (zh) * | 2022-04-21 | 2023-08-08 | 复旦大学附属儿科医院 | 一种Angptl3敲除的鼠永生化足细胞系及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2379152A1 (en) * | 1999-07-16 | 2001-01-25 | Hyseq, Inc. | Novel angiopoietin materials and methods |
| JP2005080508A (ja) * | 2003-09-04 | 2005-03-31 | Sankyo Co Ltd | 脂質代謝改善剤の試験方法 |
| CN1980686A (zh) * | 2004-04-05 | 2007-06-13 | 安斯泰来制药有限公司 | 抗肥胖药 |
| WO2006014678A2 (en) * | 2004-07-20 | 2006-02-09 | Genentech, Inc. | Compositions and methods of using angiopoietin-like 4 protein |
| AU2007227251A1 (en) * | 2006-03-20 | 2007-09-27 | Amgen Fremont, Inc. | Antibodies directed to angiopoietin-like protein 4 and uses thereof |
| EP2155207A2 (en) * | 2007-05-31 | 2010-02-24 | Government Of The United States Of America As Represented by Secretary of the Dep. of Health and Human Services National Institute of Health | N-acetyl mannosamine as a therapeutic agent |
-
2011
- 2011-06-06 PT PT117905349T patent/PT2575858T/pt unknown
- 2011-06-06 WO PCT/US2011/039255 patent/WO2011153525A2/en not_active Ceased
- 2011-06-06 KR KR1020137000446A patent/KR20130132375A/ko not_active Ceased
- 2011-06-06 EP EP17206254.9A patent/EP3318269B1/en active Active
- 2011-06-06 AU AU2011261196A patent/AU2011261196B2/en active Active
- 2011-06-06 EP EP11790534.9A patent/EP2575858B1/en active Active
- 2011-06-06 ES ES11790534T patent/ES2663096T3/es active Active
- 2011-06-06 JP JP2013513408A patent/JP5904560B2/ja active Active
- 2011-06-06 DK DK11790534.9T patent/DK2575858T3/en active
- 2011-06-06 CN CN201180034162.1A patent/CN103140234B/zh active Active
- 2011-06-06 CA CA2801579A patent/CA2801579C/en active Active
- 2011-06-06 CN CN201611046936.3A patent/CN107412729A/zh active Pending
- 2011-06-06 PL PL11790534T patent/PL2575858T3/pl unknown
- 2011-06-06 NO NO11790534A patent/NO2575858T3/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013528625A5 (https=) | ||
| JP2012115277A5 (https=) | ||
| PH12019500074A1 (en) | Novel fatty acid modified urocortin-2 analogs for the treatment of diabetes and chronic kidney disease | |
| JP7144402B2 (ja) | Ｍｇ５３突然変異体、その作製方法、およびその使用 | |
| JP2014530253A5 (https=) | ||
| JP2012176978A5 (https=) | ||
| IL308807B1 (en) | Combination therapy for cancer treatment | |
| JP2011526886A5 (https=) | ||
| JP2013515057A5 (https=) | ||
| JP2013515055A5 (https=) | ||
| WO2009053339A3 (en) | Cholesterol derivatives of inhibitors of viral fusion | |
| WO2011036442A3 (en) | Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders | |
| WO2012006598A3 (en) | Stabilized insulinotropic peptides and methods of use | |
| MX366906B (es) | Purificacion de iduronato-2-sulfatasa. | |
| WO2009121759A3 (en) | Use of pegylated igf-i variants for the treatment of neuromuscular disorders | |
| WO2011014825A3 (en) | Antiangiogenic small molecules and methods of use | |
| WO2011157447A3 (en) | Modified parvovirus having enhanced anti-tumour efficacy | |
| EA201500632A1 (ru) | Применение гербицидов на основе ингибитора als для контроля нежелательной растительности в посевах, устойчивых к гербицидам, на основе ингибитора als растений вета vulgaris | |
| US11649267B2 (en) | Mitrecin A polypeptide with antimicrobial activity | |
| CA2839298C (en) | Anti-inflammatory pharmaceutical products | |
| JP2007535910A5 (https=) | ||
| WO2008103378A3 (en) | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist | |
| WO2012177660A3 (en) | Leukotoxin e/d as a new anti-inflammatory agent and microbicide | |
| JP2016516054A5 (https=) | ||
| JP2010083896A5 (https=) |